DACUDOSES S p lav opht en récipient unidose 16Unid/10ml

Boric acid........................................................................................................................................................... 0,180 g

Borax......................................................................................................................................................................... 0,120 g

For a single-dose container of 10 mL

Excipient with known effect: Turkish rose concentrate.

Eye irrigation in case of conjunctival irritation.

Ophthalmic use.

Dosage

For ocular irrigation.

1 to 4 ocular irrigations per day as needed.

Method of administration

Irrigations are performed directly by jet, by turning the bottle upside down and gently pressing on it, taking care not to bring the bottle into contact with the surface of the eye and wiping off the excess with a compress or absorbent cotton.

Each single-dose container contains a sufficient quantity of medicine for treatment of both eyes.

Hypersensitivity to one of the active substances or to one of the excipients listed in section Composition.

Do not inject, do not swallow.

This treatment is not a treatment for irritation due to contact lenses.

This product may be used in patients wearing contact lenses; however, it is advised to remove them before performing eye irrigation.

This medicine contains a fragrance containing allergens: citronellol, geraniol, benzyl alcohol, linalool, eugenol, which may cause allergic reactions.

Wash hands thoroughly before performing eye irrigation.

This solution is presented in a single-use container.

The single-dose container must be discarded immediately after use and must not be stored for reuse.

In case of concomitant treatment with an eye drop containing a different active ingredient, space the instillations by 15 minutes.

DACUDOSES, ophthalmic irrigation solution in single-dose container has no or negligible influence on the ability to drive vehicles and use machines.

A transient visual disturbance may be felt after instillation of the eye drops in solution.

In this case, it is advised not to drive or use machines until normal vision returns.

Transient visual discomfort after instillation of the ophthalmic solution.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: www.signalement-sante.gouv.fr.

In case of overdose, rinse with sterile physiological saline.

Pharmacotherapeutic class: OTHER ANTI-INFECTIVES (S = Sensory Organs), ATC code: S01AX07

Mechanism of action

Not applicable.

Pharmacodynamic effects

Sterile solution buffered to pH 7,7.

Clinical efficacy and safety

Not applicable.

2 years.

After use, the single-dose container must be discarded.

Do not reuse a single-dose container that has already been opened.

No special requirements.